Component
Transient colour vision disturbance and increased light sensitivity
Transient colour vision disturbance and increased light sensitivity. Species, exposure and limitations are retained in each linked claim.
2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
Early in development it was noted that besides its major inhibitory effect on the intended target, the vascular-associated PDE5, the drug also exerts a lesser but definite inhibitory effect on the closely related PDE6 located in the retina, and for this reason preclinical evaluation included electroretinography plus postmortem histology and an extended eye examination was incorporated into clinical protocols, with data on the incidence, duration and type of colour vision defects observed at different doses.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sildenafil-research/10703120.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "fc004205f7e036cf52e469c5f9941c4f69d216a012ccd8a588052b950c1077e6", "start_char": 0, "end_char": 2146, "text_sha256": "fc004205f7e036cf52e469c5f9941c4f69d216a012ccd8a588052b950c1077e6"}
- experimental_model
- Review of how the ocular safety profile was established from preclinical work through to post-marketing surveillance
- exposure
- Electroretinography and histology in preclinical evaluation, with extended eye examination in clinical protocols and registry surveillance
- limitations
- A methodological review of how the signal was tracked rather than a new measurement. It is useful because it records that the retinal effect was predicted before it was looked for.
- nutrient_topic
- Sildenafil research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from its N-desmethyl metabolite and its target enzyme from the homologous retinal PDE6. · Sildenafil
- organism
- Human and animal
- plain_language
- The visual effect was not a surprise; the homology between the two enzymes predicted it and the trials were designed to look for it.
- primary_references
- [sil-p10703120] Ocular safety of Viagra, (sildenafil citrate). (1999). https://pubmed.ncbi.nlm.nih.gov/10703120/
- tissue_or_cell_type
- Retina
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Review of how the ocular safety profile was established from preclinical work through to post-marketing surveillance · source_derived_draft · unverified_draft
### sil-the-off-target-was-predicted Early in development it was noted that besides its major inhibitory effect on the intended target, the vascular-associated PDE5, the drug also exerts a lesser but definite inhibitory effect on the closely related PDE6 located in the retina, and for this reason preclinical evaluation included electroretinography plus postmortem histology and an extended eye examination was incorporated into clinical protocols, with data on the incidence, duration and type of colour vision defects observed at different doses. Condition category: normal nutrient_topic: Sildenafil research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from its N-desmethyl metabolite and its target enzyme from the homologous retinal PDE6. plain_language: The visual effect was not a surprise; the homology between the two enzymes predicted it and the trials were designed to look for it. organism: Human and animal tissue_or_cell_type: Retina experimental_model: Review of how the ocular safety profile was established from preclinical work through to post-marketing surveillance limitations: A methodological review of how the signal was tracked rather than a new measurement. It is useful because it records that the retinal effect was predicted before it was looked for. exposure: Electroretinography and histology in preclinical evaluation, with extended eye examination in clinical protocols and registry surveillance evidence_span: {"source_cache": "artifacts/sildenafil-research/10703120.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "fc004205f7e036cf52e469c5f9941c4f69d216a012ccd8a588052b950c1077e6", "start_char": 0, "end_char": 2146, "text_sha256": "fc004205f7e036cf52e469c5f9941c4f69d216a012ccd8a588052b950c1077e6"} [sil-p10703120] Ocular safety of Viagra, (sildenafil citrate). (1999). https://pubmed.ncbi.nlm.nih.gov/10703120/
Complete structured claim and evidenceSildenafil has a mild inhibitory effect on PDE6, which controls the level of cyclic guanosine monophosphate in the retina, and it may cause a perception of bluish haze or increased light sensitivity in some patients, with long-term retinal damage not reported although long-term electroretinographic studies have not been performed; the drug causes a mild lowering of blood pressure and is contraindicated in patients taking any form of nitrate medication.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sildenafil-research/10541153.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "8c5d3c6e9d606690e6cc997086ded515a4e9f785561a7fc58fdbfb75b3f0a79a", "start_char": 0, "end_char": 1024, "text_sha256": "8c5d3c6e9d606690e6cc997086ded515a4e9f785561a7fc58fdbfb75b3f0a79a"}
- experimental_model
- Review of the ophthalmic profile shortly after marketing approval
- exposure
- Reported visual effects at therapeutic doses
- limitations
- A short review written in the first year of marketing. It records explicitly that long-term electroretinographic studies had not been performed, which is the limitation that matters for the claim.
- nutrient_topic
- Sildenafil research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from its N-desmethyl metabolite and its target enzyme from the homologous retinal PDE6. · Sildenafil
- organism
- Human
- plain_language
- The colour disturbance some people notice is the same drug reaching the retinal version of the enzyme.
- primary_references
- [sil-p10541153] Sildenafil (Viagra) and ophthalmology. (1999). https://pubmed.ncbi.nlm.nih.gov/10541153/ DOI: 10.1016/s0039-6257(99)00079-x
- tissue_or_cell_type
- Retina
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Review of the ophthalmic profile shortly after marketing approval · source_derived_draft · unverified_draft
### sil-transient-visual-disturbance Sildenafil has a mild inhibitory effect on PDE6, which controls the level of cyclic guanosine monophosphate in the retina, and it may cause a perception of bluish haze or increased light sensitivity in some patients, with long-term retinal damage not reported although long-term electroretinographic studies have not been performed; the drug causes a mild lowering of blood pressure and is contraindicated in patients taking any form of nitrate medication. Condition category: normal nutrient_topic: Sildenafil research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from its N-desmethyl metabolite and its target enzyme from the homologous retinal PDE6. plain_language: The colour disturbance some people notice is the same drug reaching the retinal version of the enzyme. organism: Human tissue_or_cell_type: Retina experimental_model: Review of the ophthalmic profile shortly after marketing approval limitations: A short review written in the first year of marketing. It records explicitly that long-term electroretinographic studies had not been performed, which is the limitation that matters for the claim. exposure: Reported visual effects at therapeutic doses evidence_span: {"source_cache": "artifacts/sildenafil-research/10541153.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "8c5d3c6e9d606690e6cc997086ded515a4e9f785561a7fc58fdbfb75b3f0a79a", "start_char": 0, "end_char": 1024, "text_sha256": "8c5d3c6e9d606690e6cc997086ded515a4e9f785561a7fc58fdbfb75b3f0a79a"} [sil-p10541153] Sildenafil (Viagra) and ophthalmology. (1999). https://pubmed.ncbi.nlm.nih.gov/10541153/ DOI: 10.1016/s0039-6257(99)00079-x
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.